Certain microRNAs in the saliva of concussion patients could help gauge the severity of concussions and predict the length of concussion symptoms.
Toxicity knocks Ardelyx s hyperkalemia hopes back to preclinic
Unexpected side effects have spelled the end for Ardelyx’s drug candidate to treat elevated potassium levels in the blood, which was in phase 3 testing.
Cytokinetics cans lead drug after phase 3 ALS wipeout
Cytokinetics canned tirasemtiv after it failed to beat placebo against the primary endpoint or any of the secondary goals in an ALS trial.
Step Pharma bags cash for CTPS1 autoimmune R D drive
The $17 million financing equips the lean French biotech to prepare its CTPS1 inhibitors for clinical testing in autoimmune disorders.
PTK6 blocker could treat or even prevent ER+ breast cancer metastasis
The enzyme PTK6 could be targeted to quell the growth of estrogen receptor-positive breast cancer, a common form of the disease.
Amsterdam beats out Milan to host EMA
After tying with Milan in a third round of voting, Amsterdam will be the new home of the European Medicines Agency.
LivaNova to offload Cardiac Rhythm unit for $190M
LivaNova will sell its Cardiac Rhythm Management business to its joint venture partner, MicroPort Scientific.
DBV climbs as peanut allergy safety data come in clean
Shares in DBV rose on the back of the data, going a little way to erasing the big drop it suffered after missing its primary efficacy endpoint.